Cross Infection

• EMA withdrawal · 2018-05-16
  EMA Withdrawn: Vibativ (telavancin) — Theravance Biopharma Ireland Umited

  The EMA has withdrawn Vibativ (telavancin) from the market in the EU, a drug indicated for bacterial pneumonia and cross-infection.

• EMA withdrawal · 2014-10-17
  EMA Withdrawn: Doribax (doripenem) — Janssen-Cilag International NV

  Doribax (doripenem) has been withdrawn from the European market by Janssen-Cilag International NV due to regulatory decision.